Methodological Quality of Retrospective Observational Studies Investigating Effects of Diabetes Monitoring Systems: a Systematic Review

Author:

Jiu Li1ORCID,Wang Junfeng1,Kamusheva Maria2,Dimitrova Maria2,Tachkov Konstantin2,Milushewa Petya2,Mitkova Zornitsa2,Petrova Guenka2,Vreman Rick1,Mantel-Teeuwisse Aukje K.1,Goettsch Wim3

Affiliation:

1. Utrecht University: Universiteit Utrecht

2. Medical University of Sofia: Medicinski universitet-Sofia

3. Zorginstituut Nederland

Abstract

Abstract Background Retrospective observational studies (ROSs) have been frequently used to investigate treatment effects of diabetes monitoring systems (DMS), i.e. medical devices to monitor blood glucose. However, due to quality concerns, the findings of such studies were often questioned by clinical, regulatory, or health technology assessment decision-makers. We aimed to conduct a systematic review to assess the methodological quality of ROSs investigating DMS effects, and to explore the trend in quality change over time. Methods Embase, PubMed, Web of Science, and Scopus were systematically searched for English-language articles published from January 2012 to March 2021. Randomized controlled trials or other prospective studies were manually excluded. The ROBINS-I (Risk Of Bias In Non-randomized Studies – of Interventions) was used for assessing RoB. To investigate the quality change over time, we divided the study into three subgroups according to publication year, and compared the proportion of studies with the same quality level among the three subgroups. Results We identified 4926 articles, of which 72 were eligible for inclusion. Twenty-six studies were published before 2018, 22 in 2018 or 2019, and 24 after 2019. The overall methodological quality was quite low, as 61 (85%) studies were graded as facing critical or serious RoB. Also, the overall methodological quality did not substantially improve over time. The major contributors to low quality included confounding, missing data, and selection of the reported results. Conclusions The retrospective observational studies investigating DMS effects generally had a high risk of bias, and this did not substantially improve in the past ten years. Thus, clinical, regulatory, or HTA decision-makers may need strategies to effectively exploit these suboptimal studies. Also, to further improve study quality, extra efforts may be needed, such as guiding the tool selection regarding quality improvement in the tools.

Publisher

Research Square Platform LLC

Reference46 articles.

1. How to write a retrospective observational study;Gardner AL;Anaesthesia,2022

2. Retrospective studies and chart reviews;Hess DR;Respir Care,2004

3. Retrospective studies–utility and caveats;Talari K;J R Coll Physicians Edinb,2020

4. Retrospective studies;Anthonisen NR;Can Respir J,2009

5. Ciani O, Federici C, Tarricone R. Current and future trends in the HTA of medical devices. InXIV Mediterranean Conference on Medical and Biological Engineering and Computing. 2016; 1345–1348.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3